Metformin use and health care utilization in patients with coexisting chronic obstructive pulmonary disease and diabetes mellitus

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is associated with persistent systemic inflammation. Anti-inflammatory therapies have been shown to decrease acute exacerbations of COPD. The antidiabetic medication metformin decreases oxidative stress and inflammation and may benefit patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Bishwakarma, Raju, Zhang, Wei, Lin, Yu-Li, Kuo, Yong-Fang, Cardenas, Victor J, Sharma, Gulshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842767/
https://www.ncbi.nlm.nih.gov/pubmed/29551895
http://dx.doi.org/10.2147/COPD.S150047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842767/
https://www.ncbi.nlm.nih.gov/pubmed/29551895
http://dx.doi.org/10.2147/COPD.S150047

Ejemplares similares